MRKR · CIK 0001094038 · operating
Marker Therapeutics, Inc. (MRKR) is a pharmaceutical preparations company incorporated in DE, listed on the Nasdaq. With a market capitalization of $26 million, Marker Therapeutics, Inc. is a micro-cap company. The stock currently trades at $1.36, down 2.89% today, with a 52-week range of $0.81–$4.07.
Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.
| Fiscal Year | EPS Diluted | EPS Basic | YoY | |
|---|---|---|---|---|
| 2024 | $-1.19 | $-1.19 | -26.6% | |
| 2023 | $-0.94 | $-0.94 | +73.7% | |
| 2022 | $-3.58 | $-3.58 | -550.9% | |
| 2021 | $-0.55 | $-0.55 | — | |
| 2020 | — | — | — | |
| 2019 | — | — | — | |
| 2018 | — | — | — | |
| 2017 | $-1.16 | $-1.16 | -61.1% | |
| 2016 | $-0.72 | $-0.36 | — | |
| 2015 | — | — | — | |
| 2014 | — | — | — | |
| 2012 | — | — | — | |
| 2011 | — | — | — |
| Report Date | Filed | Accession Number | |
|---|---|---|---|
| 2024-12-31 | 2025-03-31 | 0001410578-25-000549 | SEC ↗ |
| 2023-12-31 | 2024-03-26 | 0001410578-24-000297 | SEC ↗ |
| 2022-12-31 | 2023-03-22 | 0001410578-23-000324 | SEC ↗ |
| 2021-12-31 | 2022-03-17 | 0001410578-22-000418 | SEC ↗ |
| 2020-12-31 | 2021-03-09 | 0001104659-21-033855 | SEC ↗ |
| 2019-12-31 | 2020-03-12 | 0001104659-20-032463 | SEC ↗ |
| 2018-12-31 | 2019-03-15 | 0001144204-19-014350 | SEC ↗ |
| 2017-12-31 | 2018-03-23 | 0001144204-18-016734 | SEC ↗ |
| 2016-12-31 | 2017-03-14 | 0001144204-17-014490 | SEC ↗ |
| 2015-12-31 | 2016-04-14 | 0001193125-16-541539 | SEC ↗ |
| 2014-12-31 | 2015-04-15 | 0001424884-15-000039 | SEC ↗ |
| 2013-12-31 | 2014-04-15 | 0001424884-14-000046 | SEC ↗ |
| 2012-12-31 | 2013-05-15 | 0001554757-13-000319 | SEC ↗ |
| 2011-12-31 | 2012-04-16 | 0001424884-12-000026 | SEC ↗ |
| 2010-12-31 | 2011-04-18 | 0001424884-11-000066 | SEC ↗ |
| 2009-12-31 | 2010-04-15 | 0001424884-10-000040 | SEC ↗ |
| 2008-12-31 | 2009-05-08 | 0001424884-09-000033 | SEC ↗ |